192 related articles for article (PubMed ID: 24733965)
1. The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes.
Abu El-Asrar AM; Siddiquei MM; Nawaz MI; Geboes K; Mohammad G
Mediators Inflamm; 2014; 2014():746415. PubMed ID: 24733965
[TBL] [Abstract][Full Text] [Related]
2. Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers.
Mohammad G; Alam K; Nawaz MI; Siddiquei MM; Mousa A; Abu El-Asrar AM
J Physiol Biochem; 2015 Sep; 71(3):359-72. PubMed ID: 26040511
[TBL] [Abstract][Full Text] [Related]
3. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
4. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
[No Abstract] [Full Text] [Related]
5. High-Mobility Group Box-1 Protein Mediates the Regulation of Signal Transducer and Activator of Transcription-3 in the Diabetic Retina and in Human Retinal Müller Cells.
Mohammad G; Jomar D; Siddiquei MM; Alam K; Abu El-Asrar AM
Ophthalmic Res; 2017; 57(3):150-160. PubMed ID: 27560926
[TBL] [Abstract][Full Text] [Related]
6. Association of HMGB1 with oxidative stress markers and regulators in PDR.
Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.
Mohammad G; Siddiquei MM; Othman A; Al-Shabrawey M; Abu El-Asrar AM
Exp Eye Res; 2013 Feb; 107():101-9. PubMed ID: 23261684
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group box-1 induces decreased brain-derived neurotrophic factor-mediated neuroprotection in the diabetic retina.
Abu El-Asrar AM; Nawaz MI; Siddiquei MM; Al-Kharashi AS; Kangave D; Mohammad G
Mediators Inflamm; 2013; 2013():863036. PubMed ID: 23766563
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
Jiang S; Chen X
Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
[TBL] [Abstract][Full Text] [Related]
10. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
Sohn E; Kim J; Kim CS; Lee YM; Kim JS
Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
[TBL] [Abstract][Full Text] [Related]
11. High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy.
Thakur V; Sadanandan J; Chattopadhyay M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019145
[TBL] [Abstract][Full Text] [Related]
12. Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.
Mohammad G; Siddiquei MM; Abu El-Asrar AM
Mediators Inflamm; 2013; 2013():510451. PubMed ID: 24347828
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus.
Wang P; Chen F; Zhang X
BMC Pharmacol Toxicol; 2020 Feb; 21(1):9. PubMed ID: 32019593
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins.
Liu L; Jiang Y; Steinle JJ
PLoS One; 2017; 12(5):e0178236. PubMed ID: 28542588
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HMGB1 Promotes Osseointegration under Hyperglycemic Condition through Improvement of BMSC Dysfunction.
Liu B; Gan X; Zhao Y; Yu H; Gao J; Yu H
Oxid Med Cell Longev; 2019; 2019():1703709. PubMed ID: 31929852
[TBL] [Abstract][Full Text] [Related]
17. Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition.
Chen XL; Zhang XD; Li YY; Chen XM; Tang DR; Ran RJ
Br J Ophthalmol; 2013 Dec; 97(12):1598-603. PubMed ID: 24133029
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammative effect of glycyrrhizin on rat thermal injury via inhibition of high-mobility group box 1 protein.
Shen L; Cui Z; Lin Y; Wang S; Zheng D; Tan Q
Burns; 2015 Mar; 41(2):372-8. PubMed ID: 25440843
[TBL] [Abstract][Full Text] [Related]
19. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.
Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y
Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
